Key result
Higher SEVR linked to ~48% lower major cardiovascular events risk per one-unit increase.
Why the study?
The predictive value of subendocardial viability ratio for cardiovascular events in the general population remains unclear.
Does a higher subendocardial viability ratio (SEVR) predict a reduced risk of major adverse cardiovascular events in a general population without prior stroke or MI?
Cohort (n=5,927)
Does a higher subendocardial viability ratio (SEVR) predict a reduced risk of major adverse cardiovascular events in a general population without prior stroke or MI?
Higher subendocardial viability ratio (SEVR) is an independent predictor of lower cardiovascular risk in the general population, particularly in the elderly.
Answers are grounded in this paper and cite their sources.
Higher SEVR was associated with lower MACE, mortality, and stroke risk; extends prior observations to a general Chinese population but should not yet change practice.
Background Subendocardial viability ratio (SEVR) is an effective indicator for evaluating the balance between myocardial oxygen supply and demand. Lower SEVR has been observed to associated with higher cardiovascular or all-cause mortality risk in specific populations. However, its predictive value for cardiovascular events in the general population remains unclear. Purpose This study aims to explore the association between SEVR and cardiovascular events and mortality in the general population. Methods We conducted a prospective cohort study on subjects without a history of stroke or myocardial infarction from a Chinese community-based cohort. SEVR was noninvasively measured through carotid artery pressure waveform analysis and was defined as the ratio of the diastolic pressure-time index to the systolic pressure-time index (Figure 1A). Participants were divided into low (SEVR < 1.3) and high (SEVR ≥ 1.3) SEVR groups. The endpoints included major adverse cardiovascular events (MACE), comprising all-cause mortality, stroke, and myocardial infarction. A restricted cubic spline analysis was applied to explore the possible nonlinear association of SEVR with MACE. Kaplan-Meier survival curves illustrated the temporal distribution of MACE across high and low SEVR groups. Univariable and multivariable Cox proportional hazard models were used to analyze the association between SEVR and endpoints. Age stratified interaction analysis was used to further explore the association between SEVR and MACE Results A total of 5927 participants were included. The mean age of participants was 62.12 ± 7.65 years. Over a mean follow-up of 3.23 ± 0.36 years, 207 (3.49%) participants experienced MACE, including 54 (0.91%) deaths, 134 (2.26%) strokes, and 38 (0.64%) myocardial infarctions. Higher SEVR was associated with increased risk of MACE (Figure 1B). The Kaplan–Meier curves showed significant differences in cumulative hazards of MACE between high and low SEVR groups (log-rank test: P<0.05) (Figure 1C). After adjusting for risk factors, each one-unit increase in SEVR significantly reduced the risks of adverse cardiovascular events: MACE decreased by 48% (HR 0.52, 95% CI 0.28-0.96), all-cause mortality decreased by 71% (HR 0.29, 95% CI 0.08-0.99), and stroke decreased by 57% (HR 0.43, 95% CI 0.20-0.91) (Table 1). In participants aged ≥ 65 years, higher SEVR was significantly associated with a reduced MACE risk (HR 0.24, 95% CI 0.11-0.53) (Table 2). Conclusion SEVR was an independent predictor of cardiovascular events in the general population. Higher SEVR was associated with the lower risk of MACE, all-cause mortality, and stroke. Notably, in the elderly population, the risk of MACE markedly decreased as SEVR increased. SEVR can be considered a valuable biomarker for the primary prevention and risk stratification of cardiovascular diseases, especially in the elderly population.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2025) conducted a cohort in General population without prior stroke or myocardial infarction (n=5,927). Subendocardial viability ratio (SEVR) vs. Lower SEVR was evaluated on Major adverse cardiovascular events (MACE), comprising all-cause mortality, stroke, and myocardial infarction (HR 0.52, 95% CI 0.28-0.96, p=<0.05). Each one-unit increase in subendocardial viability ratio was associated with a 48% reduced risk of major adverse cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: